Discovery XT Maintenance Agreement

Added: Jan 13, 2016 5:57 pm

This notice is a Notice of Intent. The Government intends to negotiate on a sole source basis with Roche Diagnostics for the procurement of a Discovery XT Maintenance Agreement. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 "Streamlined Procedures for Evaluation and solicitation for commercial Items," as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are not being requested and a written solicitation will not be issued. Submit offers on NOI-RML-C-1772931.

This acquisition is a Notice of Intent (NOI). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-85 effective 1 Jan 2016.

The North American Industry Classification System (NAICS) code for this procurement is 334516 with a small business size standard of 500 employees. This requirement is not set aside for small business.

The National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories, is seeking to purchase a Standard Support and Maintenance Agreement for the Discovery XT. FOB Point shall be Destination; Hamilton, MT 59840.

Place of Performance:
Rock Mountain Laboratories
903 South 4th Street
Hamilton, MT 59840
United States

Award will be based on the capability of the item offered to meet the above stated salient characteristics, price, past performance, delivery, warranty, and the best value to the government.

The following FAR provisions apply to this acquisition:
52.212-1 Instructions to Offerors Commercial Items (Oct 2015)
FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Nov 2015)
Offerors must complete annual representations and certifications on-line at http://www.sam.gov in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items
The following contract clauses apply to this acquisition:
FAR 52-212-4 Contract Terms and Conditions Commercial Items (May 2015)
FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (Jan 2016)
FAR 52.204-16 Commercial and Government Entity Code Reporting (July 2015)
FAR 52.204-18 Commercial and Government Entity Code Maintenance (July 2015)
52.203-98, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
52.203-99, Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (DEVIATION 2015-02)
52.222-25 Affirmative Action Compliance (Apr 1984)
52.204-13 - System for Award Management Maintenance (Jul 2013)
52.204-19 Incorporation by Reference of Representations and Certifications.
As prescribed in 4.1202(b), insert the following clause.
Incorporation by Reference of Representations and Certifications (Dec 2014)
52.204-16 Commercial and Government Entity Code Reporting (July 2015)
52.204-18 Commercial and Government Entity Code Maintenance (July 2015)
52.232-40 Providing accelerated Payments to Small Business Subcontractors (Dec 2013)
The Contractor's representations and certifications, including those completed electronically via the System for Award Management (SAM), are incorporated by reference into the contract.
The following HHSAR applies to this acquisition:
HHSAR 352-222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (January 2010)

The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html or, upon request, either by telephone or fax.

This is an open-market Notice of Intent for Roche Diagnostics Discovery XT Standard Support and Maintenance Agreement as defined herein. The government intends to award a purchase order as a result of this combined synopsis/solicitation that will include the terms and conditions set forth herein. To facilitate the award process all quotes must include a statement regarding the terms and conditions herein as follows:
"The Terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion or addition."
OR
"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"
(Quoter shall list exception(s) and rationale for the exception(s).)

Submission shall be received not later than 1/22/2016 4:00 p.m. MST.

Offers may be mailed, e-mailed or faxed to Peggy Schott at 406-363-9288 or margaret.schott@nih.gov. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f)

All responsible sources may submit an offer that will be considered by this Agency.
Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Peggy Schott at the email listed above.